Showing 1 - 7 results of 7 for search '"Villejuif"', query time: 0.04s Refine Results
  1. 1
    Biological embodiment of educational attainment and future risk of breast cancer: findings from a French prospective cohort

    Biological embodiment of educational attainment and future risk of breast cancer: findings from a French prospective cohort by Cyrille Delpierre, Raphaële Castagné, Eloïse Berger, Gianluca Severi, Marie-Christine Boutron-Ruault, Laura Baglietto, Laure Dossus, Amandine Gelot, Richard Dudouet

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Editorial: The immune response to therapeutic antibodies

    Editorial: The immune response to therapeutic antibodies by Michael G. Tovey, Arno J. Kromminga, Daniel T. Mytych

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Bois pourri et santé des forêts : exemple du mélange épicéa (Picea abies [L.] Karst.) et mélèze (Larix decidua Mill.) en forêt subalpine de Sainte-Foy-Tarentaise (Savoie)

    Bois pourri et santé des forêts : exemple du mélange épicéa (Picea abies [L.] Karst.) et mélèze (Larix decidua Mill.) en forêt subalpine de Sainte-Foy-Tarentaise (Savoie) by Nicolas Bernier, Jean-Yves Trosset

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?

    Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer? by Tommaso Porcelli, Cristina Luongo, Anna Cerbone, Carmine Di Luccio, Mariantonia Nacchio, Maria Angela De Stefano, Martin Schlumberger, Domenico Salvatore

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial

    Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACO... by David Malka, Philippe Laramée, Mondher Toumi, Jean-Baptiste Trouiller, Bérengère Macabeo, Andrew Poll, Dan Howard, Andy Buckland, Marine Sivignon, Emilie Clay, Emmanuelle Samalin

    Published 2022-11-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Influence of ethnicity on cyclin-dependent kinase inhibitor efficacy and toxicity: A systematic review and meta-analysis

    Influence of ethnicity on cyclin-dependent kinase inhibitor efficacy and toxicity: A systematic review and meta-analysis by Roberto Buonaiuto, Aldo Caltavituro, Margherita Tafuro, Alessandra Longobardi, Giuliana Pavone, Pierluigi De Santis, Roberta Caputo, Carmine De Angelis, Lucia Del Mastro, Fabio Puglisi, Mario Giuliano, Grazia Arpino, Martina Pagliuca, Michelino De Laurentiis

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort

    First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort by Nicolas Adamus, Julien Edeline, Julie Henriques, Nadim Fares, Thierry Lecomte, Anthony Turpin, Dewi Vernerey, Mathilde Vincens, Brice Chanez, David Tougeron, Christophe Tournigand, Eric Assenat, Matthieu Delaye, Sylvain Manfredi, Olivier Bouché, Nicolas Williet, Angelique Vienot, Lorraine Blaise, Léo Mas, Cindy Neuzillet, Alice Boilève, Gaël S. Roth

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: